Multi-Center Study of Aflibercept Therapy for Neovascular Age-Related Macular Degeneration Using Trreat and Extend Strategy
Not Applicable
Recruiting
- Conditions
- eovascular age-related macular degeneration
- Registration Number
- JPRN-UMIN000016152
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Local Steroid Therapy within 3 momths 2. Previous history of anti-VEGF treatments 3. Past history of photodynamic therapy 4. Severe cataract 5. Local or systemic infection 6. Hisrory of uveitis 7. Apahakic eyes 8. Uncontrolled hypertension 9. Cerebrovascular or cardiac vascular accident within 6 months 10. Renal failure requiring dyalisis 11. Allegy for fluorescsin and indocyaningreen dye 12. Pregnancy or lactating 13. Other conditions that the principal investigator points out
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The changes in visual acuity during 1-year after aflibercept therapy
- Secondary Outcome Measures
Name Time Method